FindTrial
Sign In

A study to understand how blood and blood products are used for the treatment of critically ill patients in the Intensive Care Unit

Blood and blood product transfusion practices in critically ill patients: A prospective observational study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/12/098268
Enrollment
200
Registered
2025-12-01
Start date
Unknown
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D50-D53- Nutritional anemias Health Condition 2: D65-D69- Coagulation defects, purpura and other hemorrhagic conditions Health Condition 3: D70-D77- Other disorders of blood and blood-forming organs

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil Intervention3: NIL: NIL

Sponsors

Postgraduate Institution of Medical Education and Research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All adult patients admitted to the main ICU during the study period will be enrolled on the day of admission.

Exclusion criteria

Exclusion criteria: 1. Patients with duration of stay less than 48 hours 2. Patients with known haematological disorder 3. Refusal to participate

Design outcomes

Primary

MeasureTime frame
Thresholds for transfusion of various blood productsTimepoint: Baseline and daily—

Secondary

MeasureTime frame
To analyse the consistency of transfusion practices with available guidelinesTimepoint: Baseline & daily;To correlate the association of transfusion with clinical outcomes (length of stay in ICU & hospital, days of mechanical ventilation, requirement of renal replacement therapy, vasopressor requirement, ICU mortality) & TRALI & TACO (as diagnosed by the clinical team)Timepoint: Baseline & daily;To analyse the incidence of anaemia in critically ill patients (Hb 12 gm per dl for females & 14 gm per dl for males)Timepoint: Baseline & daily;To analyse average Hb in critically ill patients adjusted for the number of PRBC units transfused & duration of ICU stayTimepoint: Baseline & daily;To analyse the volume of blood sampled each day (routine & on-demand) & its correlation with anaemiaTimepoint: Baseline & daily;To analyse the frequency of reports of laboratory investigations (haemogram & coagulogram) within the normal rangeTimepoint: Baseline & daily—

Countries

India

Contacts

Public ContactNeeru Sahni

Postgraduate Institute of Medical Education and Research

neerunalin@yahoo.com9872646106

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026